{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:04:33Z","timestamp":1766390673852,"version":"3.41.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec><jats:title>Purpose of review<\/jats:title><jats:p>The review gives an updated overview of some of the new concepts in the management of psoriatic arthritis (PsA): early diagnosis, remission as an objective, treat-to-target, and treatment guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Recent findings<\/jats:title><jats:p>Early diagnosis, targeting remission as part of a treatment strategy, and new guidelines providing evidence-based support to these concepts are main topics in recent publications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>Dermatologists and rheumatologists should work together to reduce the number of patients remaining undiagnosed, and the time to do so.<\/jats:p><jats:p>Remission definition in PsA is still controversial. There is good evidence and convincing arguments for both multidimensional measures, such as minimal disease activity, or unidimensional ones, as disease activity index for PsA. New data on the analysis of tight control of inflammation in early PsA trial showed that the strategy might not be cost-effective on the short term, and that oligoarthritis is less benefited.<\/jats:p><jats:p>The new European League Against Rheumatism and Group for Research and Assessment of Psoriasis and PsA recommendations exhibit differences. Methotrexate and tumor necrosis factor inhibitors are favored in European League Against Rheumatism guidelines, whereas other conventional synthetic disease-modifying antirheumatic drugs and biologics are equally positioned in Group for Research and Assessment of Psoriasis and PsA recommendations.<\/jats:p><\/jats:sec>","DOI":"10.1097\/bor.0000000000000468","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T19:12:01Z","timestamp":1507921921000},"page":"87-93","source":"Crossref","is-referenced-by-count":5,"title":["Psoriatic arthritis: new evidence for old concepts"],"prefix":"10.1097","volume":"30","author":[{"given":"Enrique R.","family":"Soriano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefina","family":"Marin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria L.","family":"Acosta-Felquer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230829","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.rdc.2015.07.004","article-title":"Natural history, prognosis, and socioeconomic aspects of psoriatic arthritis","volume":"41","author":"Helliwell","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.12688\/f1000research.9592.1","article-title":"Recent advances in understanding and managing psoriatic arthritis","volume":"5","author":"Gladman","year":"2016","journal-title":"F1000Res"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","article-title":"Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2012-201706","article-title":"High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires","volume":"72","author":"Haroon","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3899\/jrheum.140474","article-title":"Prevalence of psoriatic arthritis in a large cohort of Brazilian patients with psoriasis","volume":"42","author":"Ranza","year":"2015","journal-title":"J Rheumatol"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/acr.22284","article-title":"Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools","volume":"66","author":"Coates","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00403-009-0981-3","article-title":"Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire","volume":"301","author":"Dominguez","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaad.2007.04.001","article-title":"The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool","volume":"57","author":"Husni","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/rheumatology\/kes306","article-title":"Validation in Spanish of a screening questionnaire for the detection of psoriatic arthritis in patients with psoriasis","volume":"52","author":"Ferreyra Garrott","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/ard.2008.089441","article-title":"Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto psoriatic arthritis screen (ToPAS)","volume":"68","author":"Gladman","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/bjd.12190","article-title":"Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study)","volume":"168","author":"Coates","year":"2013","journal-title":"Br J Dermatol"},{"key":"R13-20230829","first-page":"216","article-title":"Recommendations for the coordinated management of psoriatic arthritis by rheumatologists and dermatologists: a Delphi study","volume":"105","author":"Canete","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/rheumatology\/kex179","article-title":"Musculoskeletal ultrasonography for psoriatic arthritis and psoriasis patients: a systematic literature review","volume":"56","author":"Zabotti","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3899\/jrheum.110505","article-title":"Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis","volume":"38","author":"Tinazzi","year":"2011","journal-title":"J Rheumatol"},{"key":"R16-20230829","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2017.05.002","article-title":"Ultrasound entheseal abnormalities at the distal interphalangeal joints and clinical nail involvement in patients with psoriasis and psoriatic arthritis, supporting the nail-enthesitis theory","author":"Acosta-Felquer","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000343607","article-title":"Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy","volume":"225","author":"Aydin","year":"2012","journal-title":"Dermatology"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/ddg.12989","article-title":"Nail involvement can predict enthesopathy in patients with psoriasis","volume":"14","author":"Castellanos-Gonzalez","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3899\/jrheum.170146","article-title":"Nail enthesis ultrasound in psoriasis and psoriatic arthritis: a report from the 2016 GRAPPA annual meeting","volume":"44","author":"Cunha","year":"2017","journal-title":"J Rheumatol"},{"issue":"(Suppl 2)","key":"R20-20230829","doi-asserted-by":"crossref","first-page":"ii93","DOI":"10.1136\/ard.2004.033225","article-title":"Psoriatic arthritis and psoriasis: role of patient advocacy organisations in the twenty first century","volume":"64","author":"Zimmerman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","article-title":"European league against rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update","volume":"75","author":"Gossec","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.2008.102053","article-title":"Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment","volume":"69","author":"Coates","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/ard.2009.122259","article-title":"Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis","volume":"69","author":"Schoels","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/acr.20155","article-title":"Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data","volume":"62","author":"Coates","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/acr.22576","article-title":"Radiographic progression of patients with psoriatic arthritis who achieve minimal disease activity in response to golimumab therapy: results through 5 years of a randomized, placebo-controlled study","volume":"68","author":"Kavanaugh","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/acr.20162","article-title":"Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort","volume":"62","author":"Coates","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13075-017-1277-1","article-title":"Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study","volume":"19","author":"Queiro","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10067-014-2626-y","article-title":"Remission criteria and activity indices in psoriatic arthritis","volume":"33","author":"Acosta Felquer","year":"2014","journal-title":"Clin Rheumatol"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"528105","DOI":"10.1155\/2014\/528105","article-title":"Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world","volume":"2014","author":"Salaffi","year":"2014","journal-title":"Biomed Res Int"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/annrheumdis-2016-209511","article-title":"Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression","volume":"76","author":"Aletaha","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3899\/jrheum.170112","article-title":"Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: a cross-sectional analysis of a longitudinal cohort","volume":"44","author":"Lubrano","year":"2017","journal-title":"J Rheumatol"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1136\/annrheumdis-2015-208509","article-title":"The definition of remission in psoriatic arthritis: can this be accurate without assessment of multiple domains?","volume":"74","author":"Helliwell","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1136\/annrheumdis-2015-208521","article-title":"Defining remission and treatment success using the DAPSA score: response to letter by Helliwell and Coates","volume":"74","author":"Schoels","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0140-6736(15)00347-5","article-title":"Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial","volume":"386","author":"Coates","year":"2015","journal-title":"Lancet"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11926-015-0517-0","article-title":"Treat to target in psoriatic arthritis-evidence, target, research agenda","volume":"17","author":"Coates","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"R37-20230829","article-title":"The cost-effectiveness of tight control of inflammation in early psoriatic arthritis: Economic analysis of the TICOPA trial","author":"O\u2019Dwyer","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1136\/annrheumdis-2017-211137","article-title":"The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial","volume":"76","author":"Coates","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrrheum.2016.183","article-title":"Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations","volume":"12","author":"Gossec","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/ard.2008.094946","article-title":"Treatment recommendations for psoriatic arthritis","volume":"68","author":"Ritchlin","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/annrheumdis-2011-200350","article-title":"European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies","volume":"71","author":"Gossec","year":"2012","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201801000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T13:38:04Z","timestamp":1750945084000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201801000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000468","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"type":"print","value":"1040-8711"},{"type":"electronic","value":"1531-6963"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}